In the stratified analysis by diverse tumor subtypes in this study, longer estrogen exposure showed better survival in ER+, PR+, and HR+ HER2+ tumors, but not in HER2+ tumors (Fig 2C and Fig C in S1 File). This evidence concerns the gene PGR and neoplasm.